References - Therapeutic Strategies in Cancer Biology and Pathology - page 263

Zhang, H., Li, M., Han, Y., Hong, L., Gong, T., Sun, L., et al., 2010b. Down-regulation of
miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.
Dig. Dis. Sci. 55, 2545-2551.
Zhang, H., Singh, R.R., Talukder, A.H., Kumar, R., 2006a. Metastatic tumor antigen 3 is a
direct co-repressor of the Wnt4 pathway. Genes Dev. 20, 2943-2948.
Zhang, H.K., Pan, K., Wang, H., Weng, D.S., Song, H.F., Zhou, J., et al., 2008a. Decreased
expression of ING2 gene and its clinicopathological significance in hepatocellular carci-
noma. Cancer Lett. 261, 183-192.
Zhang, H.Y., Rumilla, K.M., Jin, L., Nakamura, N., Stilling, G.A., Ruebel, K.H., et al., 2006b.
Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-
catenin with metastasis in small bowel carcinoid tumors. Endocrine 30, 299-306.
Zhang, J., Smolen, G.A., Haber, D.A., 2008b. Negative regulation of YAP by LATS1 under-
scores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res. 68,
2789-2794.
Zhang, J., Ji, J.Y., Yu, M., Overholtzer, M., Smolen, G.A., Wang, R., et al., 2009b. YAP-
dependent induction of amphiregulin identifies a non-cell-autonomous component of the
Hippo pathway. Nat. Cell Biol. 11, 1444-1450.
Zhang, M., Volpert, O., Shi, Y.H., Bouck, N., 2000. Maspin is an angiogenesis inhibitor. Nat.
Med. 6, 196-199.
Zhang, R., He, Y., Zhang, X., Xing, B., Sheng, Y., Lu, H., et al., 2012b. Estrogen receptor-
regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocar-
cinoma and precancerous lesions. Cancer Lett. 314, 155-165.
Zhang, S., Hao, J., Xie, F., Hu, X., Liu, C., Tong, J., et al., 2011a. Downregulation of miR-132
by promoter methylation contributes to pancreatic cancer development. Carcinogenesis
32, 1183-1189.
Zhang, S., Kim, K., Jin, U.H., Pfent, C., Cao, H.J., Amendt, B., et al., 2012c. Aryl hydrocar-
bon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of
estrogen receptor negative breast cancer cells. Mol. Cancer Ther. 11, 108-118.
Zhang, W., Zhang, M., 2002. Tissue microarray analysis of maspin expression and its reverse
correlation with mutant p53 in various tumors. Int. J. Oncol. 20, 1145-1150.
Zhang, W., Cheng, G.Z., Gong, J., Hermanto, U., Zong, C.S., Chan, J., et al., 2008c.
RACK1 and CIS mediate the degradation of BimEL in cancer cells. J. Biol. Chem. 283,
16416-16426.
Zhang, X., Xu, L.S., Wang, Z.Q., Wang, K.S., Li, N., Cheng, Z.H., et al., 2004. ING4 induces
G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in
HepG2 cells. FEBS Lett. 570, 7-12.
Zhang, X., Wang, K.S., Wang, Z.Q., Xu, L.S., Wang, Q.W., Chen, F., et al., 2005. Nuclear
localization signal of ING4 plays a key role in its binding to p53. Biochem. Biophys.
Res. Commun. 331, 1032-1038.
Zhang, X.M., Gu, H., Yan, L., Zhang, G.Y., 2013. RKIP inhibits the malignant phenotypes of
gastric cancer cells. Neoplasma 60, 196-202.
Zhang, Y., Laterra, J., Pomper, M.G., 2009c. Hedgehog pathway inhibitor HhAntag691 is a
potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia 11, 96-101.
Zhang, Y., Yan, L.X., Wu, Q.N., Du, Z.M., Chen, J., Liao, D.Z., et al., 2011b. miR-125b is
methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene
in human invasive breast cancer. Cancer Res. 71, 3552-3562.
Zhang, Y., Xu, R., Li, G., Xie, X., Long, J., Wang, H., 2012d. Loss of expression of the dif-
ferentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with
metastasis of non-small cell ljung carcinoma cells. Tumour Biol. 33, 1915-1925.